Graf Acquisition Corp. IV Currently Has Proxies from More Than 65% of its Stockholders to Approve Extension
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination
Graf Acquisition Corp. IV Withdraws Extension Proposal
About · FAQs · StocksCafe © 2024 · Privacy · Terms